Lipum Q3 report - Next step underway
2023-10-31 11:05:00
Redeye provides a research update on Lipum following the Q3 report published by the company earlier today. We make some minor adjustments to our estimates following a lower cash burn than expected. However, we reiterate our fair value range (SEK4 – SEK32) with a base case valuation of SEK20 as we continue to have a positive outlook on the case.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/